Kelley Lee | |
---|---|
Alma mater | University of British Columbia (BA) University of Victoria (MPA) University of Sussex (MA, DPhil) |
Scientific career | |
Institutions | London School of Hygiene & Tropical Medicine Simon Fraser University |
Kelley Lee (born May 5, 1962) is a Tier 1 Canada Research Chair in Global Health Governance and Professor of Global Public Health in the Faculty of Health Sciences at Simon Fraser University. She has studied the impact of globalisation on public health, with a particular focus on the tobacco industry. During the COVID-19 pandemic Lee initiated and led the Pandemics and Borders Project to understand effective ways to mitigate the spread of SARS-CoV-2 through the effective use of travel measures.
Lee earned her bachelor's degree at the University of British Columbia. [1] She moved to the University of Victoria to complete a Master of Public Administration, before joining the University of Sussex to specialise in international relations. [1] She completed a doctorate in international political economy at the University of Sussex before joining the London School of Hygiene & Tropical Medicine in 1992.
Lee led the World Health Organization Collaborating Centre on Global Change and Health at the London School of Hygiene & Tropical Medicine. [2] Here she led the Public and Environmental Health Research Unit and studied the relationships between trade and global health. [3] Whilst some argue that globalisation only drives inequality, others believe that it is a positive force which will eventually improve the lives of all. [4] Her work considered how global health intersected with foreign policy. [5] In particular, Lee works on tobacco control and the globalisation of communicable and non-communicable diseases. Whilst Lee believed that the WHO Framework Convention on Tobacco Control was an important achievement, she has argued that the WHO must take into account the increasing globalisation of the tobacco industry. [6]
She joined Simon Fraser University (SFU) in 2011 where she was appointed Associate Dean for Research and Director of Global Health. [1] At SFU Lee led the Global Tobacco Control Research Programme. She was appointed a Canada Research Chair in Global Health Governance in 2015. [7] Her chair was renewed in 2022. Lee has investigated the role of the WHO in international health cooperation and its role in supporting collective action in response to global health challenges. [8] Her research has shown that collective action and cooperation is essential to improve the global response to pandemics, including severe acute respiratory syndrome (SARS), Ebola and HIV/AIDS. In 2018 Lee was selected by the Canadian Society for International Health as one of the leading women in global health. [9]
Lee is leading a Canadian Institutes of Health Research (CIHR) research program to evaluate the efficacy of coronavirus prevention strategies. [10] She looked to define and categorise the various measures adopted by countries and corporations, and compare these approaches with datasets from historical pandemic responses. [10] [11] By understanding the effectiveness of various prevention strategies, Lee looks to mitigate the spread of SARS-CoV-2. [12] When asked by the Rolling Stone magazine what she thought of the WHO response to coronavirus disease, Lee was impressed by their proactive approach, "it has kept us informed. It has mobilized scientists and coordinated data and research. It has collected the best evidence and tried to put forward very clear guidance about what should be done. The big question is whether we've given it enough authority and resources to act the way we want it to act". [13] She believes that the WHO struggles to respond quickly to emerging disasters because of underfunding, as well as trying to deal with global politics and bureaucracy. [13] She has said that SARS-CoV-2 may cause the world to ask profound questions about how we govern the world, "I used to say it would take a really big outbreak or catastrophe. Now it's here. We've got it. If we can learn from this one we'll be so much better equipped for the next one. But people just don't want to face those questions". [13]
Lee has said that people who smoke and vape are at a greater risk to become infected by coronavirus disease. [14] Researchers in Wuhan identified that smokers were fourteen times more likely to have coronavirus disease progression. [14] Lee has called for British Columbia Ministry of Health to expand their Smoking Cessation Program during the outbreak. [15]
Simon Fraser University (SFU) is a public research university in British Columbia, Canada, with three campuses, all in Greater Vancouver: Burnaby, Surrey, and Vancouver. The 170-hectare (420-acre) main Burnaby campus on Burnaby Mountain, located 15 kilometres (9.3 mi) from downtown Vancouver, was established in 1965 and comprises more than 30,000 students and 160,000 alumni. The university was created in an effort to expand higher education across Canada.
Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.
Laurie Garrett is an American science journalist and author. She was awarded the Pulitzer Prize for Explanatory Journalism in 1996 for a series of works published in Newsday that chronicled the Ebola virus outbreak in Zaire.
A public health emergency of international concern is a formal declaration by the World Health Organization (WHO) of "an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response", formulated when a situation arises that is "serious, sudden, unusual, or unexpected", which "carries implications for public health beyond the affected state's national border" and "may require immediate international action". Under the 2005 International Health Regulations (IHR), states have a legal duty to respond promptly to a PHEIC. The declaration is publicized by an IHR Emergency Committee (EC) of international experts, which was developed following the 2002–2004 SARS outbreak.
Devi Lalita Sridhar FRSE is an American public health researcher, who is both professor and chair of global public health at the University of Edinburgh, Scotland. Her research considers the effectiveness of public health interventions and how to improve developmental assistance for health. Sridhar directs the University of Edinburgh's Global Health Governance Programme which she established in 2014.
Michael Joseph Ryan is an Irish epidemiologist and former trauma surgeon, specialising in infectious disease and public health. He is executive director of the World Health Organization's Health Emergencies Programme, leading the team responsible for the international containment and treatment of COVID-19. Ryan has held leadership positions and has worked on various outbreak response teams in the field to eradicate the spread of diseases including bacillary dysentery, cholera, Crimean–Congo hemorrhagic fever, Ebola, Marburg virus disease, measles, meningitis, relapsing fever, Rift Valley fever, SARS, and Shigellosis.
Bruce Aylward is a Canadian physician and epidemiologist. Since September 2017 he has been Senior Advisor to the Director-General of the World Health Organization. He is part of the implementation of the WHO's COVAX Facility. He has past experience in the areas of polio eradication, Zika virus, and Ebola.
Trudie Lang is a Professor of Global Health Research at the University of Oxford. She specialises in clinical trials research capacity building in low-resource setting, and helped to organise the trial for the drug brincidofovir during the 2014 Ebola virus outbreak.
Azra Catherine Hilary Ghani is a British epidemiologist who is a professor of Infectious Disease Epidemiology at Imperial College London. Her research considers the mathematical modelling of infectious diseases, including malaria, bovine spongiform encephalopathy and coronavirus. She has worked with the World Health Organization on their technical strategy for malaria. She is associate director of the MRC Centre for Global Infectious Disease Analysis.
Maria DeJoseph Van Kerkhove is an American infectious disease epidemiologist. With a background in high-threat pathogens, Van Kerkhove specializes in emerging and re-emerging infectious diseases and is based in the Health Emergencies Program at the World Health Organization (WHO). She is the technical lead of COVID-19 response and the head of emerging diseases and zoonosis unit at WHO.
Bonnie J. Fraser Henry is a Canadian epidemiologist, physician, and public servant who has been the provincial health officer at the British Columbia Ministry of Health since 2014. Henry is also a clinical associate professor at the University of British Columbia. She is a specialist in public health and preventive medicine, and is a family doctor. In her role as provincial health officer, Henry notably led the response to COVID-19 in British Columbia (BC).
Caitlin M. Rivers is an American epidemiologist who as Senior Scholar at the Johns Hopkins Center for Health Security and assistant professor at the Johns Hopkins Bloomberg School of Public Health, specializing on improving epidemic preparedness. Rivers is currently working on the American response to the COVID-19 pandemic with a focus on the incorporation of infectious disease modeling and forecasting into public health decision making.
Alexandra Louise Phelan is an associate professor at Johns Hopkins Bloomberg School of Public Health and senior scholar at the Johns Hopkins Center for Health Security. She specializes in international legal and policy issues that are related to emerging and reemerging infectious diseases, including upstream drivers of disease emergence like climate change.
Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.
Helen Branswell is a Canadian infectious diseases and global health reporter at Stat News. Branswell spent fifteen years as a medical reporter at The Canadian Press, where she led coverage of the Ebola, Zika, SARS and swine flu pandemics. She joined Stat News at its founding 2015, leading the website's coverage of the ongoing COVID-19 pandemic.
Eleanor N. Fish is a Canadian immunologist who is a Professor of Immunology at the University of Toronto. Her research considers how cytokines and chemokines interact with receptors in cells and tissue. During the COVID-19 pandemic, Fish tested interferon-alpha as a treatment for coronavirus disease.
Helena Legido-Quigley is a Spanish public health researcher who is an associate professor in Health Systems at Saw Swee Hock School of Public Health at the National University of Singapore. She serves as an associate fellow of Chatham House and is a member of the Council of the World Economic Forum. She is editor-in-chief of Elsevier's Journal of Migration and Health.
Caroline Colijn is a Canadian mathematician and epidemiologist. She holds a Canada 150 Research Chair in Mathematics for Evolution, Infection and Public Health at Simon Fraser University (SFU).
Saskia Popescu is an infectious disease epidemiologist and global health security expert in Phoenix, Arizona. She is an Assistant Professor of epidemiology at the University of Maryland, and holds academic appointments at the University of Arizona and George Mason University’s Schar School of Policy and Government, where she lectures on biopreparedness and outbreak response. Since the start of the Coronavirus disease 2019 pandemic, Popescu has worked to prepare for and mitigate the spread of the disease within healthcare and the entertainment industry, where she led the global epidemiology and infection prevention response for Netflix. She has been recognized for her communication efforts around the pandemic, as well as her work on the front lines in infection prevention and healthcare biopreparedness. Popescu currently is a Senior Fellow at the Council on Strategic Risks, addressing converging biological risks from biological weapons nonproliferation, biosecurity, emerging infectious diseases and ecological security, biopreparedness in private industry, and global health security vulnerabilities.
Suerie Moon is a Korean American public health expert who is Professor of Practice at the Graduate Institute of International and Development Studies. Her research considers global health, health equity and pandemic preparedness.
{{cite book}}
: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)